SynCraft: Guiding Large Language Models to Predict Edit Sequences for Molecular Synthesizability Optimization
Junren Li, Luhua Lai
TL;DR
SynCraft addresses the gap between computational design and practical synthesis by reframing synthesizability optimization as targeted, atom-level editing guided by chain-of-thought reasoning in LLMs. It decouples strategic planning from chemical execution, using a Retrieval-Augmented Inference pipeline and an interaction-aware prompting strategy to preserve pharmacophores while navigating the synthesis cliff with surgical edits. Across large-scale benchmarks, SynCraft outperforms projection-based baselines, replicates expert medicinal chemistry intuition in retrospective PLK1 cases, and demonstrates prospective rescue of shelved RIPK1 candidates through bioisosteric edits and scaffold hopping. The work delivers explainable, chemistry-grounded AI edits with practical implications for high-value hit optimization and suggests a scalable path toward manufacturable AI-designed molecules.
Abstract
Generative artificial intelligence has revolutionized the exploration of chemical space, yet a critical bottleneck remains that a substantial fraction of generated molecules is synthetically inaccessible. Current solutions, such as post-hoc filtering or projection-based methods, often compromise structural novelty or disrupt key pharmacophores by forcing molecules into pre-defined synthetic templates. Herein, we introduce SynCraft, a reasoning-based framework that reframes synthesizability optimization not as a sequence translation task, but as a precise structural editing problem. Leveraging the emergent reasoning capabilities of Large Language Models, SynCraft navigates the "synthesis cliff" where minimal structural modifications yield significant gains in synthetic feasibility. By predicting executable sequences of atom-level edits rather than generating SMILES strings directly, SynCraft circumvents the syntactic fragility of LLMs while harnessing their chemical intuition. Extensive benchmarks demonstrate that SynCraft outperforms state-of-the-art baselines in generating synthesizable analogs with high structural fidelity. Furthermore, through interaction-aware prompting, SynCraft successfully replicates expert medicinal chemistry intuition in editing PLK1 inhibitors and rescuing high-scoring but previously discarded RIPK1 candidates in previous molecular generation literatures.
